Premature ejaculation is one of the most common sexual dysfunctions occurring in men. Ejaculation happens sooner than desired, either shortly or before penetration, resulting in distress to either one or both partners involved in sexual intercourse. There is no exact cause that can be associated with the condition though mostly, premature ejaculation can be attributed to personal distress and anxiety. It can affect an individual’s relationship with his partner. Premature ejaculation is the most common sexual disorder found in men aged between 18 to 59. Some of the effective treatment options available include psychological counseling, medications, sexual techniques that delay ejaculation, or a combination of these treatments.
Technavio’s analysts forecast the global premature ejaculation treatment market to grow at a CAGR of 8.71% during the period 2017-2021.
Covered in this report The report covers the present scenario and the growth prospects of the global premature ejaculation treatment market for 2017-2021. To calculate the market size, the report considers the sales of branded, generic, and off-label drugs.
The market is divided into the following segments based on geography: • Americas • APAC • EMEA
Technavio’s report, Global Premature Ejaculation Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors • Absorption Pharmaceuticals • Bayer • Eli Lilly • Regent Pacific Group
Other prominent vendors • Dong-A Pharmaceutical • Emcure • Futura Medical • GlaxoSmithKline • NeuroHealing Pharmaceuticals • Pfizer
Market driver • High use of off-label drugs • For a full, detailed list, view our report
Market challenge • Alternative treatments • For a full, detailed list, view our report
Market trend • Growing online retail sales of drugs • For a full, detailed list, view our report
Key questions answered in this report • What will the market size be in 2021 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Our reports have been used by over 10K customers, including:
Muscle Atrophy - Pipeline Review, H2 2019 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Muscle Atrophy - Pipeline Review, H2 2019, provides an overview of the Muscle Atrophy (Musculoskeletal Disorders) pipeline landscape. Muscle atrophy is the wasting or loss of...
Retinoic Acid Receptor Beta - Pipeline Review, H2 2019 Summary According to the recently published report ’Retinoic Acid Receptor Beta - Pipeline Review, H2 2019’; Retinoic Acid Receptor Beta (RAR Beta or HBV Activated Protein or Nuclear Receptor Subfamily 1 Group B Member 2 or RAR Epsilon or NR1B2...
Prostaglandin E2 Receptor EP4 Subtype - Pipeline Review, H2 2019 Summary Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) pipeline Target constitutes close to 15 molecules. Out of which approximately 14 molecules are developed by companies and remaining by the universities/institutes....
Osteomyelitis - Pipeline Review, H2 2019 Summary Pharmaceutical and Healthcare disease pipeline guide Osteomyelitis - Pipeline Review, H2 2019, provides an overview of the Osteomyelitis (Infectious Disease) pipeline landscape. Osteomyelitis is an infection in a bone. Infections can reach a...
Fragile X Syndrome - Pipeline Review, H2 2019 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Fragile X Syndrome - Pipeline Review, H2 2019, provides an overview of the Fragile X Syndrome (Genetic Disorders) pipeline landscape. Fragile X syndrome is a genetic condition...
Thalassemia - Pipeline Review, H2 2019 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Thalassemia - Pipeline Review, H2 2019, provides an overview of the Thalassemia (Hematological Disorders) pipeline landscape. Thalassemia is a group of inherited blood disorders...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.